<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.businessinsider.my/stocks-to-short-10-stocks-hedge-funds-shorted-goldman-says-2019-11/"/>
    <meta property="og:site_name" content="Business Insider Malaysia"/>
    <meta property="article:published_time" content="2019-11-25T19:44:21+00:00"/>
    <meta property="og:title" content="These are the top 10 stocks that hedge funds are betting the most against"/>
    <meta property="og:description" content="In the first weeks of November, hedge funds revealed the stocks they’re betting on, and data also showed the ones they’re betting against."/>
  </head>
  <body>
    <article>
      <h1>These are the top 10 stocks that hedge funds are betting the most against</h1>
      <address><time datetime="2019-11-25T19:44:21+00:00">25 Nov 2019, 19:44</time> by <a rel="author">Carmen Reinicke, Business Insider US</a></address>
      <figure>
        <img src="https://www.businessinsider.my/assets/placeholders/ap-image-placeholder.jpg"/>
      </figure>
      <ul>
        <li>
          <b>In its November Hedge Fund Trend Monitor report, Goldman Sachs released a list of the top stocks shorted by hedge funds.</b>
        </li>
        <li>
          <b>Goldman uses the total dollar value of short interest outstanding to estimate hedge fund short portfolio holdings, according to the report.</b>
        </li>
        <li>
          <b>“Short positions continue to contribute alpha, lifting the average equity hedge fund to a 10% YTD return,” Goldman analysts wrote in the report.</b>
        </li>
        <li>
          <b>Here are the top 10 stocks that firms are betting against.</b>
        </li>
        <li>
          <b>
            <a href="https://www.businessinsider.com/">Read more on Business Insider.</a>
          </b>
        </li>
      </ul>
      <p>In the first weeks of November, hedge funds <a href="https://markets.businessinsider.com/news/stocks/stocks-buy-10-companies-loved-hedge-funds-goldman-sachs-q3-2019-11-1028705442">revealed the stocks they’re betting on</a>, and data also showed the ones they’re betting against.</p>
      <p>Goldman Sachs analyzed 833 hedge funds with $2.1 trillion in gross equity positions – including $700 billion short positions – for its Hedge Fund Trend Monitor report released November 18.</p>
      <p>From the analysis, Goldman compiled its “Very Important Short Position List” as a short hedge against the most-loved stocks firms own.</p>
      <p>The list contains 50 S&amp;P 500 companies with the highest dollar value of short interest outstanding, excluding companies on the long list and stocks with more than 10% of float-adjusted shares held short. The total dollar value of short interest outstanding is used as an estimate of hedge fund short portfolio holdings, according to the report.</p>
      <p>“Short positions continue to contribute alpha, lifting the average equity hedge fund to a 10% YTD return,” Goldman analysts wrote in the report. That still lagged the S&amp;P 500 index return of 27% for the same period.</p>
      <p>After a few “sluggish” months, hedge fund performance is sharply rebounding in the fourth quarter, according to Goldman. The “Very Important Short” basket has lagged the S&amp;P 500 by 6 percentage points this year, and stocks with the highest short interest as a share of market cap have returned a median of -5% year-t0-date, according to the report.</p>
      <p>Here are the top 10 stocks that represent the largest short positions, ranked in order of increasing value of short interest.</p>
      <hr/>
      <h3>10. Chevron</h3>
      <figure>
        <img src="https://static.businessinsider.sg/2019/11/11/5ddc1fecfd9db23612664f49.png"/>
        <figcaption>FILE PHOTO: Chevron (CVX)’s logo is seen in Los Angeles<cite>Reuters</cite></figcaption>
      </figure>
      <p><b>Ticker:</b> <a href="https://markets.businessinsider.com/stocks/cvx-stock">CVX</a></p>
      <p><b>Short interest as % of float cap:</b> 1%</p>
      <p><b>Year-to-date return:</b> 15%</p>
      <p><b>Number of hedge funds with stock as a top 10 holding:</b> 2</p>
      <p><b>Value of short interest:</b> $2.4 billion</p>
      <p>
        <i>Source: Goldman Sachs</i>
      </p>
      <hr/>
      <h3>9. UnitedHealth Group</h3>
      <figure>
        <img src="https://www.businessinsider.my/assets/placeholders/ap-image-placeholder.jpg"/>
      </figure>
      <p><b>Ticker:</b> <a href="https://markets.businessinsider.com/stocks/unh-stock">UNH</a></p>
      <p><b>Short interest as % of float cap:</b> 1%</p>
      <p><b>Year-to-date return:</b> 10%</p>
      <p><b>Number of hedge funds with stock as a top 10 holding:</b> 11</p>
      <p><b>Value of short interest:</b> $2.6 billion</p>
      <p>
        <i>Source: Goldman Sachs</i>
      </p>
      <hr/>
      <h3>8. BB&amp;T Corp.</h3>
      <figure>
        <img src="https://static.businessinsider.sg/2019/11/11/5ddc20eefd9db22e764869cf.png"/>
        <figcaption>People walk past a BB&amp;T bank in Alexandria, Virginia July 22, 2010<cite>REUTERS/Molly Riley</cite></figcaption>
      </figure>
      <p><b>Ticker:</b> <a href="https://markets.businessinsider.com/stocks/bbt-stock">BBT</a></p>
      <p><b>Short interest as % of float cap:</b> 6%</p>
      <p><b>Year-to-date return:</b> 30%</p>
      <p><b>Number of hedge funds with stock as a top 10 holding:</b> 1</p>
      <p><b>Value of short interest:</b> $2.6 billion</p>
      <p>
        <i>Source: Goldman Sachs</i>
      </p>
      <hr/>
      <h3>7. Home Depot</h3>
      <figure>
        <img src="https://static.businessinsider.sg/2019/03/03/5c8299b6262898099b0687e4.png"/>
        <figcaption>
          <cite>Joe Raedle / Getty Images</cite>
        </figcaption>
      </figure>
      <p><b>Ticker:</b> <a href="https://markets.businessinsider.com/stocks/hd-stock">HD</a></p>
      <p><b>Short interest as % of float cap: </b>1%</p>
      <p><b>Year-to-date return:</b> 41%</p>
      <p><b>Number of hedge funds with stock as a top 10 holding:</b> 10</p>
      <p><b>Value of short interest:</b> $2.6 billion</p>
      <p>
        <i>Source: Goldman Sachs</i>
      </p>
      <hr/>
      <h3>6. Procter &amp; Gamble</h3>
      <figure>
        <img src="https://static.businessinsider.sg/2019/10/10/5d96075f625ac91f2d773ff8.png"/>
        <figcaption>Procter &amp; Gamble’s Head &amp; Shoulders is seen in a store in Manhattan, New York, U.S.<cite>Thomson Reuters</cite></figcaption>
      </figure>
      <p><b>Ticker:</b> <a href="https://markets.businessinsider.com/stocks/pg-stock">PG</a></p>
      <p><b>Short interest as % of float cap:</b> 1%</p>
      <p><b>Year-to-date return:</b> 35%</p>
      <p><b>Number of hedge funds with stock as a top 10 holding:</b> 3</p>
      <p><b>Value of short interest:</b> $2.8 billion</p>
      <p>
        <i>Source: Goldman Sachs</i>
      </p>
      <hr/>
      <h3>5. Exxon Mobil</h3>
      <figure>
        <img src="https://static.businessinsider.sg/2019/11/11/5a344306b0bcd5f7018b5604.png"/>
        <figcaption>Darren Woods, Chairman &amp; CEO of Exxon Mobil Corporation attends a news conference at the New York Stock Exchange (NYSE) in New York, U.S., March 1, 2017.<cite>REUTERS/Brendan McDermid</cite></figcaption>
      </figure>
      <p><b>Ticker:</b> <a href="https://markets.businessinsider.com/stocks/xom-stock">XOM</a></p>
      <p><b>Short interest as % of float cap:</b> 1%</p>
      <p><b>Year-to-date return:</b> 6%</p>
      <p><b>Number of hedge funds with stock as a top 10 holding:</b> 1</p>
      <p><b>Value of short interest:</b> $2.9 billion</p>
      <p>
        <i>Source: Goldman Sachs</i>
      </p>
      <hr/>
      <h3>4. Intel Corp.</h3>
      <figure>
        <img src="https://static.businessinsider.sg/2018/10/10/5bb39aad9a4ab8196c50be32.png"/>
        <figcaption>
          <cite>Alexander Tolstykh/Shutterstock</cite>
        </figcaption>
      </figure>
      <p><b>Ticker:</b> <a href="https://markets.businessinsider.com/stocks/intc-stock">INTC</a></p>
      <p><b>Short interest as % of float cap: </b>1%</p>
      <p><b>Year-to-date return:</b> 27%</p>
      <p><b>Number of hedge funds with stock as a top 10 holding:</b> 3</p>
      <p><b>Value of short interest:</b> $3.2 billion</p>
      <p>
        <i>Source: Goldman Sachs</i>
      </p>
      <hr/>
      <h3>3. AT&amp;T Inc.</h3>
      <figure>
        <img src="https://static.businessinsider.sg/2019/11/11/5ddc216afd9db22d5e3c5a47.png"/>
        <figcaption>
          <cite>
            <a href="https://www.flickr.com/photos/jeepersmedia/16318416090/in/photolist-qS19zy-qcy8jS-qS19DS-nnaNSV-nL2AWC-oWDTno-nvKYzz-nfapcD-nN6nEw-pdSefc-nDEx3F-kTzDBz-oqkCJt-nvLvxY-nN6gRs-nyr234-nL2mAp-GjSPR9-oqj9YY-oNR95h-oq4p6p-o89NKj-nN6nwW-FX4jau-qUEsUx-osLR3L-ApqHoh-oVibDe-onBFpf-oViccD-opC4ao-p6kRMZ-pb4jD9-o3p3gb-pXh9Jw-pXh9Jm-7TSTFC-pY32wr-nN67BA-BjDVSU-onBFwu-oNRD7J-oNR66b-o8akuz-p6kRwZ-oS2M2c-p65Cjc-p6iQAb-oNRBLY-p4iQWN">Mike Mozart/flickr</a>
          </cite>
        </figcaption>
      </figure>
      <p><b>Ticker:</b> <a href="https://markets.businessinsider.com/stocks/t-stock">T</a></p>
      <p><b>Short interest as % of float cap: </b>1%</p>
      <p><b>Year-to-date return:</b> 47%</p>
      <p><b>Number of hedge funds with stock as a top 10 holding: </b>3</p>
      <p><b>Value of short interest:</b> $4 billion</p>
      <p>
        <i>Source: Goldman Sachs</i>
      </p>
      <hr/>
      <h3>2. AbbVie Inc.</h3>
      <figure>
        <img src="https://static.businessinsider.sg/2019/11/11/5ddc217afd9db22d8d08ce85.png"/>
        <figcaption>FILE PHOTO: A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange<cite>Reuters</cite></figcaption>
      </figure>
      <p><b>Ticker:</b> <a href="https://markets.businessinsider.com/stocks/abbv-stock">ABBV</a></p>
      <p><b>Short interest as % of float cap:</b> 4%</p>
      <p><b>Year-to-date return:</b> 2%</p>
      <p><b>Number of hedge funds with stock as a top 10 holding:</b> 8</p>
      <p><b>Value of short interest:</b> $5.2 billion</p>
      <p>
        <i>Source: Goldman Sachs</i>
      </p>
      <hr/>
      <h3>1. Bristol-Myers Squibb</h3>
      <figure>
        <img src="https://static.businessinsider.sg/2019/11/11/5dd52a21fd9db264cb0efad4.png"/>
        <figcaption>Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage<cite>Reuters</cite></figcaption>
      </figure>
      <p><b>Ticker:</b> <a href="https://markets.businessinsider.com/stocks/bmy-stock">BMY</a></p>
      <p><b>Short interest as % of float cap:</b> 9%</p>
      <p><b>Year-to-date return:</b> 17%</p>
      <p><b>Number of hedge funds with stock as a top 10 holding:</b> 11</p>
      <p><b>Value of short interest:</b> $8.5 billion</p>
      <p>
        <i>Source: Goldman Sachs</i>
      </p>
    </article>
  </body>
</html>